Nanomaterials for Disease Treatment by Modulating the Pyroptosis Pathway
Advanced Healthcare Materials · 2024-01 · 13 (1)
DOI: 10.1002/adhm.202301266 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 06.07.2023. Verfasst von Mengzhen Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, 266021, P. R. …. Hauptthemen laut MEDLINE: Pyroptosis, Nanostructures. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 171 Literaturangaben. Gefördert von: Taishan Scholar Youth Expert Program in Shandong Province, Grants for Scientific Research of Distinguished Professor from Qingdao University, China.
Abstract (Originalsprache)
Pyroptosis differs significantly from apoptosis and cell necrosis as an alternative mode of programmed cell death. Its occurrence is mediated by the gasdermin protein, leading to characteristic outcomes including cell swelling, membrane perforation, and release of cell contents. Research underscores the role of pyroptosis in the etiology and progression of many diseases, making it a focus of research intervention as scientists explore ways to regulate pyroptosis pathways in disease management. Despite numerous reviews detailing the relationship between pyroptosis and disease mechanisms, few delve into recent advancements in nanomaterials as a mechanism for modulating the pyroptosis pathway to mitigate disease effects. Therefore, there is an urgent need to fill this gap and elucidate the path for the use of this promising technology in the field of disease treatment. This review article delves into recent developments in nanomaterials for disease management through pyroptosis modulation, details the mechanisms by which drugs interact with pyroptosis pathways, and highlights the promise that nanomaterial research holds in driving forward disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, 266021, P. R. China.
ORCID-Profile: Qinrui Fu
Förderung
- Taishan Scholar Youth Expert Program in Shandong Province
- Grants for Scientific Research of Distinguished Professor from Qingdao University, China
Zitieren
APA
Wang, M., & Fu, Q. (2024). Nanomaterials for Disease Treatment by Modulating the Pyroptosis Pathway. Advanced Healthcare Materials, 13(1). https://doi.org/10.1002/adhm.202301266
Vancouver
Wang M, Fu Q. Nanomaterials for Disease Treatment by Modulating the Pyroptosis Pathway. Advanced Healthcare Materials. 2024;13(1). doi:10.1002/adhm.202301266
BibTeX
@article{Wang2024,
author = {Wang, Mengzhen and Fu, Qinrui},
title = {Nanomaterials for Disease Treatment by Modulating the Pyroptosis Pathway},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {1},
doi = {10.1002/adhm.202301266}
}
EUVIMED